u.s. Pharmaceutical Industry to u.s. Government: "Improve Korean Drug Price Policy as Leverage in Trade Negotiations"

연합뉴스-Yonhap News Agency

Lean Right

Factuality

Ownership

(Washington=Yonhap News) Correspondent Kim Dong-hyun = The U.S. pharmaceutical industry has named Korea as a country that is causing damage to the U.S. by artificially lowering the prices of medicines exported to the U.S.

Naver

Factuality

Ownership

The Pharmaceutical Research and Manufacturers of America (PhRMA) has demanded that the U.S. government use trade negotiations to improve Korea's drug pricing policy, claiming that Korea and other countries are artificially setting low prices for U.S. drugs, causing harm to the U.S. The U.S. is also considering improving Korea's drug pricing policy in trade negotiations with Korea.